Key clinical point: Enrollment of black patients in phase 1 gynecologic oncology clinical trials is 1,750%-5,300% lower than expected, depending on cancer site studied.
Major finding: The enrollment ratio in ovarian cancer studies was 0.04:1 for black and white patients, respectively, while the ratios for endometrial and cervical cancer were 0.004:1 and 0.025:1, respectively.
Study details: A review of 357 studies involving 9,492 patients.
Disclosures: Mr. Awad reported having no disclosures.
Awad E et al. SGO 2019, Abstract 22.